Charles Schwab Investment Management Inc Alector, Inc. Transaction History

Charles Schwab Investment Management Inc

$519 Billion
Q2 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Alector, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 666,461 shares of ALEC stock, worth $3.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

666,461

Previous 674,790 1.23%

Holding current value

$3.28 Million

Previous $4.06 Million 25.53%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$4.19 - $6.23 $34,898 - $51,889	-8,329 Reduced 1.23%	666,461 $3.03 Million
Q1 2024 May 08, 2024	BUY	$5.69 - $8.08 $997,235 - $1.42 Million	175,261 Added 35.09%	674,790 $4.06 Million
Q4 2023 Feb 06, 2024	BUY	$3.77 - $8.39 $65,247 - $145,205	17,307 Added 3.59%	499,529 $3.99 Million
Q3 2023 Nov 08, 2023	BUY	$5.2 - $8.77 $65,358 - $110,230	12,569 Added 2.68%	482,222 $3.12 Million
Q2 2023 Aug 09, 2023	BUY	$5.86 - $7.93 $62,737 - $84,898	10,706 Added 2.33%	469,653 $2.82 Million
Q1 2023 May 11, 2023	BUY	$5.85 - $9.84 $20,463 - $34,420	3,498 Added 0.77%	458,947 $2.84 Million
Q4 2022 Feb 13, 2023	BUY	$6.88 - $9.55 $70,024 - $97,199	10,178 Added 2.29%	455,449 $4.2 Million
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $141,383 - $227,871	17,263 Added 4.03%	445,271 $4.21 Million
Q2 2022 Aug 15, 2022	BUY	$7.65 - $14.24 $40,636 - $75,642	5,312 Added 1.26%	428,008 $4.35 Million
Q1 2022 May 13, 2022	BUY	$13.02 - $20.78 $129,262 - $206,303	9,928 Added 2.41%	422,696 $6.02 Million
Q4 2021 Feb 11, 2022	BUY	$19.35 - $25.54 $128,793 - $169,994	6,656 Added 1.64%	412,768 $8.52 Million
Q3 2021 Nov 16, 2021	BUY	$21.65 - $39.49 $691,046 - $1.26 Million	31,919 Added 8.53%	406,112 $9.27 Million
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $442,633 - $641,961	28,557 Added 8.26%	374,193 $7.8 Million
Q1 2021 May 17, 2021	BUY	$14.84 - $22.23 $170,600 - $255,556	11,496 Added 3.44%	345,636 $6.96 Million
Q4 2020 Feb 16, 2021	SELL	$9.4 - $16.7 $5,969 - $10,604	-635 Reduced 0.19%	334,140 $5.06 Million
Q3 2020 Nov 13, 2020	BUY	$10.54 - $24.96 $677,416 - $1.6 Million	64,271 Added 23.76%	334,775 $3.53 Million
Q2 2020 Aug 14, 2020	BUY	$21.87 - $33.11 $931,530 - $1.41 Million	42,594 Added 18.69%	270,504 $6.61 Million
Q1 2020 May 15, 2020	BUY	$16.25 - $35.28 $739,960 - $1.61 Million	45,536 Added 24.97%	227,910 $5.5 Million
Q4 2019 Feb 07, 2020	BUY	$14.17 - $20.3 $56,991 - $81,646	4,022 Added 2.26%	182,374 $3.14 Million
Q3 2019 Nov 08, 2019	BUY	$14.42 - $22.2 $1.75 Million - $2.7 Million	121,608 Added 214.31%	178,352 $2.57 Million
Q2 2019 Aug 09, 2019	BUY	$16.26 - $26.42 $158,876 - $258,149	9,771 Added 20.8%	56,744 $1.08 Million
Q1 2019 May 14, 2019	BUY	$15.97 - $22.5 $750,158 - $1.06 Million	46,973 New	46,973 $880,000

Others Institutions Holding ALEC

# of Institutions

165

Shares Held

58.1M

Call Options Held

57K

Put Options Held

14.9K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $406M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Alector, Inc. Transaction History